Why would a 44-year-old man take clomiphene citrate (Clomid)?

Why Would a 44-Year-Old Man Take Clomiphene Citrate (Clomid)?

A 44-year-old man would most commonly take clomiphene citrate (Clomid) for male infertility with low testosterone while attempting to preserve fertility, or as an alternative to testosterone replacement therapy when fertility preservation is desired. 1

Primary Indications in Men

1. Male Infertility with Low Testosterone

Clomiphene is used off-label in infertile men with low serum testosterone to increase endogenous testosterone production and improve spermatogenesis. 1 The drug works as a selective estrogen receptor modulator (SERM) that blocks negative feedback at the hypothalamus and pituitary, thereby increasing LH and FSH secretion, which stimulates testicular testosterone production and sperm development.

Key points about this indication:

• Guideline support: The 2021 AUA/ASRM guidelines state that clinicians may use SERMs (including clomiphene) for infertile men with low serum testosterone (Conditional Recommendation, Grade C evidence) 1
• Real-world use: In a US claims database study, 52% of men taking clomiphene had a diagnosis of male infertility, and 13.5% had testicular hypofunction 2
• Efficacy: Meta-analysis shows clomiphene increases sperm concentration (mean difference 8.38 × 10⁶/ml) and motility (mean difference 8.14%) 3
• Pregnancy rates: Studies report pregnancy rates averaging 17% (range 0-40%) during clomiphene treatment 3

2. Hypogonadism with Fertility Preservation

For men with symptomatic hypogonadism who desire to maintain fertility, clomiphene is a critical alternative to testosterone replacement therapy. 4, 5 This is particularly relevant for a 44-year-old man who may still be in his reproductive years.

Critical distinction:

• Testosterone therapy suppresses sperm production and can cause azoospermia, making it contraindicated in men desiring fertility 1
• Clomiphene maintains or improves fertility while raising testosterone levels 4, 5
• Long-term data shows 88% of men achieve eugonadism and 77% report improved symptoms when treated for >3 years 4

3. Idiopathic Infertility

Clomiphene may be prescribed for men with unexplained infertility and normal testosterone levels, though guidelines note limited benefits compared to assisted reproductive technology (ART). 1

Important caveats:

• The 2021 AUA/ASRM guidelines explicitly state that "clinicians should inform the man with idiopathic infertility that the use of SERMs has limited benefits relative to results of ART" 1
• Benefits are small and may be outweighed by IVF/ICSI, which offer higher pregnancy rates and faster conception 1

Critical FDA Labeling Caveat

The FDA label explicitly states: "There are no adequate or well-controlled studies that demonstrate the effectiveness of clomiphene citrate in the treatment of male infertility." 6 The label also warns that "testicular tumors and gynecomastia have been reported in males using clomiphene," though causality is not established. 6

This creates a tension between:

• FDA position: Not approved for male use; no proven effectiveness
• Clinical practice: Widely used off-label with guideline support (albeit conditional)
• Real-world data: Increasing usage (12,318 men in US claims database 2001-2014) with no increased adverse events 2

Safety Profile

The safety data is reassuring for clinical use:

• No serious adverse events reported in multiple studies 7, 2, 4
• Most common side effects (when treated >3 years): mood changes (5 patients), blurred vision (3 patients), breast tenderness (2 patients) 4
• No increased risk of thrombotic events, vision problems, or liver disease in claims database analysis 2
• Mean treatment duration: 19-25 months in long-term studies 4, 5

Dosing and Monitoring Patterns

Typical prescribing (though highly variable in practice 8):

• Starting dose: 25 mg every other day, titrated to 50 mg every other day 5
• Target testosterone: ~550 ± 50 ng/dL 5
• Monitoring: Testosterone, LH, FSH, estradiol levels; semen analysis in infertility cases 2
• Duration: Median 3.6 months (63% stop within 6 months), though some continue for years 2, 4

Clinical Decision Algorithm

For a 44-year-old man, clomiphene would be appropriate if:

1. Infertility is present (attempting conception with partner) AND low testosterone

   • Clomiphene is preferred over testosterone therapy
   • Consider ART if female partner has fertility issues or time is critical

2. Hypogonadal symptoms (low libido, erectile dysfunction, fatigue) with low testosterone AND desire for fertility preservation

   • Clomiphene allows symptom treatment without compromising fertility
   • Alternative to lifelong testosterone dependency

3. Post-testosterone therapy recovery (though not explicitly in guidelines)

   • May help restore endogenous production after anabolic steroid use

Clomiphene would NOT be appropriate if:

• Hypogonadotropic hypogonadism (HH) is present—these patients need gonadotropins or pulsatile GnRH 1
• Fertility is not a concern—testosterone replacement is more effective for symptom relief
• Female partner has normal fertility and time allows—ART may be more efficient 1

Bottom Line

The most likely reason a 44-year-old man takes clomiphene is to treat low testosterone while preserving fertility for current or future conception attempts. This represents off-label use with conditional guideline support, reasonable efficacy data, and excellent safety profile, but limited benefits compared to ART in idiopathic infertility cases. The 2025 EAU guidelines list clomiphene under drug-induced causes of hypogonadism (as an ER blocker) 9, highlighting its mechanism but not contradicting its therapeutic use in appropriate contexts.